Result of Meeting and TVR

Summary by AI BETAClose X

Abingdon Health PLC announced that all resolutions proposed at its General Meeting on October 30, 2025, were duly passed, satisfying a condition for completion of its Fundraising. Application has been made for admission of 57,441,821 new Ordinary Shares to trading on AIM, expected to commence around October 31, 2025, at 8:00 a.m. Following admission, the Company's issued ordinary share capital will comprise 251,072,642 Ordinary Shares, representing the total number of voting rights. Executive Chairman Chris Hand purchased 500,000 ordinary shares at 6 pence per share, increasing his holding to 13,678,467 shares, representing 5.4% of the enlarged share capital. Quality and Regulatory Director Candice Vendettuoli purchased 33,333 ordinary shares at 6 pence per share, holding 0.01% of the enlarged share capital.

Disclaimer*

UK 100

Latest directors dealings